Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA legislation

This article was originally published in The Gray Sheet

Executive Summary

Existing 15% limit on Medicare payment reductions made by the Health Care Financing Administration under its inherent reasonableness authority would be repealed by a bill (S 1451) introduced July 28 by Sen. Tom Harkin (D-Iowa). The measure also provides a mechanism by which the agency could reduce Medicare payment levels for durable medical equipment. Separately, Rep. Robert Ney (R-Ohio) introduces legislation (HR 2689) on Aug. 3 that would impose a one-year moratorium on the promulgation of rules or regulations imposing new requirements, with the exception of mandated items, while the agency holds public hearings on any regs in development and submits a report to Congress on the proposals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel